Advances in Cancer ImmunotherapyTM Webinar: Clinical Updates from SITC 2020: Claim Credit

aci17-Online-clr.png

The SITC Advances in Cancer Immunotherapy™ Webinar: Clinical Updates from SITC 2020, held on March 30, 2021, is available for continuing education credits. 

 

Continuing Education Credit Information
Continuing Education Credits are available for physicians, nurses and pharmacists. To view full accreditation information, click
here.

 

Request Credit

  1. Click the Register Now button.
  2. You will be prompted to log in or create a free account.
  3. Click the Request Credit/Certificate button.
  4. On the Manage Your Credit screen, follow the instructions to select the Credit Reporting Organization you wish to claim credit for. (Note: For pharmacist completers, enter your NABP# (required). For physicians claiming MOC credit, enter your ABIM# (required)). Then click Continue.
  5. Successfully complete the post-test with a score of 75% or better.
  6. Complete the evaluation. Then click Submit.
  7. On the Confirm All Information screen, verify your Credit Reporting Organization and click Process Credit.
  8. On the Education Credit Profile screen, scroll down to the Submitted Credit section to view your certificate. 

 

For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor. Parmacists have up to thirty (30) days to complete the evaluation and claim credit. Please check you NABP account within thirty (30) days to make sure the credit has posted.

 

Target Audience

The webinar is intended for clinical oncologists, registered nurses, nurse practitioners, advanced practice registered nurses, pharmacists, physician assistants, emergency physicians, allied health professionals, other patient care providers, students and patient advocates.


Webinar Learning Objectives

  • Summarize and integrate the most recent advances in cancer immunotherapy
  • Analyze cutting-edge clinical trials to incorporate new research and techniques into clinical application for cancer immunotherapy
  • Define the types of resistance to PD-1 pathway inhibitors


Webinar Faculty

  • Moderator: Jason Luke, MD – University of Pittsburgh Medical Center
  • Presenters:
    • Diwakar Davar, MD – University of Pittsburgh Medical Center
    • Karl Lewis, MD – University of Colorado
    • Ignacio Melero, MD, PhD – Fundación para la Investigación Médica Aplicada
    • Hussein Tawbi, MD, PhD – MD Anderson Cancer Center

 

On-demand Webinar

The recorded webinar video and slides will be available here within 24 hours after the webinar concludes.

(Please note that the on-demand webinars are not available for continuing education credits.) 

 

 

Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.

PIM_logo.png sitc_log_color.png
 

 

The 2020–2021 Advances in Cancer Immunotherapy™ educational series is supported, in part, by independent medical education grants from Amgen, AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, Exelixis, Inc., and Merck & Co., Inc. 

Advances in Cancer ImmunotherapyTM Webinar: Clinical Updates from SITC 2020: Claim Credit
Individual topic purchase: Selected
Accreditation Council for Continuing Medical Education (MD/DO)
AMA PRA Category 1 Credit(s)™: 1.00
Accreditation Council for Continuing Medical Education (non-MD/DO)
AMA PRA Category 1 Credit(s)™: 1.00
Accreditation Council for Pharmacy Education
Contact Hour: 1.00
(0.1 CEUs)
American Nurses Credentialing Center's Commission on Accreditation
Contact Hour: 1.00
Designated for 0.75 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses
Certificate of Participation (No Credit)
Certificate of Participation: 0.00
Accreditation Council for Continuing Medical Education and ABIM Maintenance of Certification
AMA PRA Category 1 Credit(s)™ / ABIM Maintenance of Certification Part 2 Credit: 1.00
Products
Advances in Cancer ImmunotherapyTM Webinar: Clinical Updates from SITC 2020: Claim Credit